Fujifilm Europe’s commitment through the Coronavirus pandemic

With the collective goal of enhancing society through innovation, the Fujifilm family in Europe is committed to leveraging its resources, talent and technologies to support global efforts to counter the COVID-19 pandemic.

Our sincere gratitude and respect go out to all the healthcare professionals that are working to save lives and aid in the prevention of COVID-19. To help improve patient outcomes throughout the care spectrum, Fujifilm appreciates clinicians that are on the front lines treating patients on a daily basis. As a company with total healthcare capabilities in Prevention, Diagnosis and Treatment, we are committed to supporting the brave clinicians caring for COVID-19 patients with our technologies.

During this time, our number one priority remains the health and safety of our 4,500 strong European workforce, our customers and the broader community. In response to the pandemic, we’ve adapted our business practices in order to safeguard our staff, as well as continue to serve our customers, many of which are powering critical operations in the fields of healthcare, technology and media.

Ensuring business continuity

implementing Business Continuity plans across all nations

developing Business Recovery plans across all nations

working from home where possible – with 80% of our workforce now working from home

proper hygiene protocols across all of our sites – and when off site

adopting any new international and national travel restrictions

prohibiting the attendance and participation in trade shows and events

directing employees who display any of the Coronavirus symptoms to report this to us and follow any recommendations by qualified healthcare professionals

Reducing the impact on our supply chains

The entire global supply chain has been impacted due to the Coronavirus outbreak, which has led to large-scale disruption in both manufacturing and shipping. Contingency plans are in place for both production and logistics. We are taking active measures to limit this impact and we are in daily contact with our logistics partners. However, considering Fujifilm’s diversified business portfolio, the supply chain impact will vary on a business-by-business basis.

Supporting Europe’s healthcare crisis

Fujifilm’s transformation, from producer of analogue photo film to a diversified company with a focus in the healthcare sector, enables the company to support the health of people around the world. Our Medical Systems business exists to serve doctors and patients and to help save lives during this pandemic. In this context, we are doing our very best to keep delivery, installations and service as steady as possible.

Fujifilm is committed to keeping you updated about developments comprehensively. However, most of all, as a company, our Management and employees want customers, partners and colleagues to stay safe and healthy. We appreciate you may have many more questions regarding Fujifilm’s local approach in your country, if you do so, please visit your local country page via our portal.

A message from Masato Yamamoto, President FUJIFILM Europe GmbH

A message from Masato “Mark” Yamamoto, President and Managing Director of FUJIFILM Europe GmbH, to Europe’s healthcare community:

Fujifilm Europe is closely monitoring and responding to the evolving COVID-19 pandemic to minimize its impact on our workforce, products and supply chain. Our number one priority is the safety of our employees, customers and the broader community. At the same time, many Fujifilm Group companies have an important role to play in working to support Europe’s healthcare community, our doctors, our nurses, our hospitals, our medical institutions and our governments, to overcome this healthcare crisis.

The Coronavirus continues to evolve at a rapid pace, and while the impact varies greatly on a country-by-country basis – it has fundamentally changed life for all of us, as well as all of you, and particularly your loved ones. It has launched an assault on all of our lives, and you are the ones at the forefront, leading the fightback.

For Fujifilm, our diagnostic instruments and utilities, be that an X-ray mobile or point of care device, or potential pharmaceutical solution that we seek to evaluate, have a particular part to play on the Coronavirus care pathway.

Our technologies and efforts at this time are focused on working alongside you, to support you, on being there where we can, to do whatever we can to help you in your efforts to save lives.

Together with our technologies, we also have our people alongside you. We have Applications Specialists and Service Engineers in the field, going through this crisis, also often at the front line, to support you. They are there to not only work with you but also to help save you time, in a moment when every second counts.

So, thank you. Today you are making a super-human effort. Thank you for your individual dedication, collective contribution and your service. We are forever grateful.

Masato Yamamoto, President and Managing Director of FUJIFILM Europe GmbH

Our response to support the healthcare community against the COVID-19 pandemic

In the acute care environment, like COVID-19, reducing the time to make an accurate diagnosis is a critical need, while ensuring patients and operators safety. Fujifilm is putting healthcare professionals at the centre, being at their side in every moment, doing our part to help them in every way we can.

Mobile X-Ray Solutions

Fujifilm’s diagnostic imaging solutions incorporate some unique features to assist healthcare providers in responding to these emergencies quickly and effectively at the patient bedside, in the emergency department, operating rooms, ICU, NICU or wherever general x-ray is needed. Designed to be truly portable and used in the most rugged environments, and with infection control in mind. Click here for more info

Pulmonary Endoscopy

Fujifilm offers a broad range of endoscopes for pulmonary indications; with a heightened awareness of respiratory symptoms amid the COVID-19 outbreak, there is an increased focus on pulmonary diagnostic exams. Our bronchoscopes increase physician productivity by making insertion into the bronchial tubes substantially easier. Click here for more info

Point-of-Care Ultrasounds

Bedside ultrasound has become a valuable tool for physicians working in critical care environments to obtain immediate clinical information, improve patient safety, increase efficiency, and decrease complications. Sonosite point of care ultrasounds incorporate unique compact size with agile mobility, and germ resistant surfaces to help improve infection controls for especially sensitive environments like COVID-19. Click here for more info

Powering your workflow - AI REiLI

The use of Artificial Intelligence (REiLI) can be a valid tool to optimize the workflow, lightening and supporting the workloads related to the diagnosis and monitoring of the course of the COVID-19 disease. In these circumstances that have never seen precedents, REiLI is in support of specialists, with a human-machine interaction that makes more efficient and supports decision-making processes.Click here for more info

Synapse 3D

Synapse 3D enables a faster and objective quantitative analysis of the onset of COVID-19 and supports the radiologist on daily exams to monitor and study the evolution of the disease, thus optimising workflow.
This new technological development is useful in improving patient management of those affected by COVID-19 during this emergency situation.
Have a look at the Fujifilm Take Away library to download our case study on how Pisa University Hospital utilised the technology to their benefit (Take Away 15) and browse a variety of other case studies on healthcare.

Radiology

Radiography now is playing a critical role in supporting radiologists and technologists in the care process of patients with COVID-19. Fujifilm delivers image quality and dose efficiency with proprietary advanced technologies. Our range of digital X-ray systems are durable, reliable and built for any type of operation, including emergency care. Our service team members are equipped to ensure that there is little-to-no downtime of these crucial diagnostic tools. Click here for more info

Avigan (favipiravir)

As a potential pharmaceutical solution to the pandemic, the clinical application of Avigan (favipiravir) to treat COVID-19 is under study. Fujifilm has commenced a phase III clinical trial in Japan to assess the safety and efficacy of Avigan in COVID-19 patients with non-severe pneumonia, alongside a phase II clinical trial in the United States.

Accelerating the manufacture of therapies and vaccines

FUJIFILM Diosynth Biotechnologies (FDB), one of the world's leading providers of contract process development and manufacturing services for the biopharmaceutical sector, based in Europe out of the UK and Denmark, is playing an active role in supporting governments, academia and industry to rapidly scale up potential COVID-19 vaccines and therapies.

FDB has teamed up with the Bill & Melinda Gates Foundation's COVID-19 Therapeutics Accelerator. The Therapeutics Accelerator is working to accelerate drug development and will identify a promising COVID-19 therapeutic candidate based on efficacy and safety data demonstrated in clinical trials. Under this agreement, FDB will allocate pharmaceutical manufacturing capacity in our large-scale biologics production facility in Hillerød, Denmark.

In addition, FUJIFILM Irvine Scientific is working to supply cell culture media and critical raw materials to numerous life science companies working to develop and manufacture therapies, vaccines, and diagnostics to combat COVID-19.

Supporting the Assisted Reproductive Technology community

The COVID-19 pandemic is having a considerable impact on many in the Assisted Reproductive Technology community. For this reason FUJIFILM Irvine Scientific has implemented a "COVID-19 Media Replacement Program" to help the laboratories get back up and running. By this program FUJIFILM Irvine Scientific will provide a "one-time" free replacement of products that have expired due to COVID-19 closures and disruptions. Products that will expire within seven days of a lab re-opening and starting new cycles will also be replaced.

Fujifilm Group companies' reaction to the pandemic

Although the current situation requires us to are supposed to keep a distance from each other, we at Fujifilm Healthcare are moving even closer together in a figurative sense right now.

Turbulent times require extraordinary measures. The Fujifilm Healthcare team continues to work at full capacity for you, so that you can continue to care for your patients with ease. Even in these difficult times, we are at your side as a competent partner.

#Fujifilm, #NeverStop Supporting #Healthcare.

Interview with Dr. Mangala Narasimhan on Responding to COVID-19 in New York.

Fujifilm Sonosite Chief Medical Officer Diku Mandavia, M.D. interviews Mangala Narasimhan, DO, a pulmonary and critical care specialist from Long Island Jewish Medical Center, part of Northwell Health in Long Island, New York. Dr. Narasimhan describes how the COVID-19 pandemic has impacted her hospital in the heart of New York's outbreak.

NEVER STOP TRANSFORMING OURSELVES AND THE WORLD

For more than 80 years, we've continued transforming ourselves. Building from our origins as a film company known for innovations like the world's first high ISO 400 film, we've evolved into a technology company working in areas such as healthcare, highly-functional materials, imaging solutions and more. By leveraging our advanced and unique technologies, we will continue creating value from innovation and contribute to solving social challenges. Which means we'll never stop building on our experience and expertise to help transform ourselves, and the world.